Hologic Taken Private in $17B Deal by Blackstone and TPG
Hologic Inc. (HOLX) ceased trading on Nasdaq after completing its acquisition by Blackstone and TPG in a deal valued at up to $79 per share. The transaction, initially announced in October 2025, received shareholder approval in February 2026. Investors received $76 per share in cash, plus contingent value rights tied to Breast Health revenue targets.
The deal structure includes minority investments from Abu Dhabi Investment Authority (ADIA) and GIC. Former CEO Stephen MacMillan retired after 12 years, succeeded by Joe Almeida. Hologic reported $4.13 billion in revenue prior to the deal's close.
Related Articles
Log in to Reply
Log in to comment your thoughtsComments